HK1255223A1 - 使用糖酵解依賴性化合物治療疾病的方法 - Google Patents

使用糖酵解依賴性化合物治療疾病的方法

Info

Publication number
HK1255223A1
HK1255223A1 HK18114352.3A HK18114352A HK1255223A1 HK 1255223 A1 HK1255223 A1 HK 1255223A1 HK 18114352 A HK18114352 A HK 18114352A HK 1255223 A1 HK1255223 A1 HK 1255223A1
Authority
HK
Hong Kong
Prior art keywords
disease
treating
dependent compound
glycolytic dependent
glycolytic
Prior art date
Application number
HK18114352.3A
Other languages
English (en)
Inventor
Galloway James
Original Assignee
Ethicon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon Inc filed Critical Ethicon Inc
Publication of HK1255223A1 publication Critical patent/HK1255223A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0042—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polymers & Plastics (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK18114352.3A 2015-08-14 2018-11-09 使用糖酵解依賴性化合物治療疾病的方法 HK1255223A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562205031P 2015-08-14 2015-08-14
PCT/US2016/046594 WO2017030908A1 (en) 2015-08-14 2016-08-11 Method of treating a disease using a glycolytic dependent compound

Publications (1)

Publication Number Publication Date
HK1255223A1 true HK1255223A1 (zh) 2019-08-09

Family

ID=56787703

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18114352.3A HK1255223A1 (zh) 2015-08-14 2018-11-09 使用糖酵解依賴性化合物治療疾病的方法

Country Status (9)

Country Link
US (2) US10960021B2 (zh)
EP (1) EP3334471B1 (zh)
CN (1) CN108136066B (zh)
AU (1) AU2016307942B2 (zh)
ES (1) ES2952093T3 (zh)
HK (1) HK1255223A1 (zh)
MA (1) MA42610A (zh)
RU (1) RU2723215C2 (zh)
WO (1) WO2017030908A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111896753A (zh) * 2020-08-19 2020-11-06 复旦大学附属肿瘤医院 一种结直肠癌患者的葡萄糖代谢分型方法及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3364200A (en) 1960-03-28 1968-01-16 Johnson & Johnson Oxidized cellulose product and method for preparing the same
US4626253A (en) 1984-10-05 1986-12-02 Johnson & Johnson Products, Inc. Surgical hemostat comprising oxidized cellulose
US5180398A (en) 1990-12-20 1993-01-19 Johnson & Johnson Medical, Inc. Cellulose oxidation by a perfluorinated hydrocarbon solution of nitrogen dioxide
US8097648B2 (en) 1998-06-17 2012-01-17 Eisai R&D Management Co., Ltd. Methods and compositions for use in treating cancer
US20040265371A1 (en) 2003-06-25 2004-12-30 Looney Dwayne Lee Hemostatic devices and methods of making same
US20060093655A1 (en) 2004-10-20 2006-05-04 Lillian Bar Method for making a reinforced absorbable multilayered hemostatic wound dressing
CN102319230A (zh) * 2011-08-12 2012-01-18 西安交通大学 可植入式5-氟尿嘧啶缓控释给药系统及其制备方法
US20130064815A1 (en) * 2011-09-12 2013-03-14 The Trustees Of Princeton University Inducing apoptosis in quiescent cells
CN103070875B (zh) * 2013-02-19 2015-01-28 福州大学 一种具有抗癌效果的组合物
US10328095B2 (en) * 2013-03-15 2019-06-25 Covidien Lp Resorbable oxidized cellulose embolization microspheres
CN104277047A (zh) * 2013-07-08 2015-01-14 复旦大学 一种具有葡萄糖转运体亲和力的靶向功能分子
CN204520963U (zh) * 2015-04-02 2015-08-05 山东省立医院 一种卵巢囊肿切除术后的卵巢包膜

Also Published As

Publication number Publication date
EP3334471C0 (en) 2023-06-21
ES2952093T3 (es) 2023-10-27
WO2017030908A1 (en) 2017-02-23
MA42610A (fr) 2018-06-20
CN108136066B (zh) 2021-11-09
EP3334471B1 (en) 2023-06-21
US11986489B2 (en) 2024-05-21
RU2018108842A (ru) 2019-09-17
RU2018108842A3 (zh) 2019-09-17
US20170042930A1 (en) 2017-02-16
RU2723215C2 (ru) 2020-06-09
US10960021B2 (en) 2021-03-30
AU2016307942B2 (en) 2021-03-25
AU2016307942A1 (en) 2018-03-01
EP3334471A1 (en) 2018-06-20
US20210154224A1 (en) 2021-05-27
CN108136066A (zh) 2018-06-08

Similar Documents

Publication Publication Date Title
HK1245078A1 (zh) 治療神經退行性疾病的方法
LT3386511T (lt) Hantingtono ligos gydymo būdai
ZA201706632B (en) Method of treating a fabric
ZA201706457B (en) Method of treating a fabric
IL253945A0 (en) kdm1a inhibitors to treat the disease
HK1252568A1 (zh) 一種治療方法
SG11201701723XA (en) Methods of treating liver disease
IL278247B (en) mct4 inhibitors to treat the disease
HK1257665A1 (zh) 用於治療線粒體疾病的新化合物
HK1252627A1 (zh) 用於向皮膚提供有益效果的方法
HK1253238A1 (zh) 用於治療疾病的gls1抑制劑
ZA201706665B (en) Method of treating a fabric
SI3393468T1 (sl) Postopki za zdravljenje bolezni imunske pomanjkljivosti
HK1253743A1 (zh) 採用lsd1抑制劑治療多發性硬化的方法
PT3164394T (pt) Inibidores gls1 para o tratamento de doenças
HK1247818A1 (zh) 治療疾病的方法
SG11201703184SA (en) A method of treatment
GB201904142D0 (en) Improved method of FT-IMS
GB201521886D0 (en) A method of treating a well
HK1247119A1 (zh) 一種治療方法和用於所述治療方法中的化合物
HK1250243A1 (zh) 治療方法
HK1255223A1 (zh) 使用糖酵解依賴性化合物治療疾病的方法
IL259914B (en) A method for producing a benzoxazole compound
GB201504413D0 (en) Treatment of disease
GB201511017D0 (en) Method of treatment